OTCQX:MRVFF - Post by User
Comment by
TurtleNamedSamon Aug 06, 2015 10:45pm
122 Views
Post# 23996724
RE:More Detailed Q2 Review/ Product Margins
RE:More Detailed Q2 Review/ Product MarginsRock07 wrote:
The patient sample size for WF10 is just 1/2 of intended levels.
This means 50 % fewer patients to monitor and 50 % less patients needing Chamber testing following the pollen season.
It also means that the statistics will be greater than 50% worse - half the number of data points means that the standard deviation will be more than twice as large as expected when the trial was devised. That is the nature of statistics.